BlackBerry and NantHealth Launch NantOmics Cancer Genome Browser

BlackBerry and NantHealth, a cloud-based information technology company has announced, the NantOmics Cancer Genome Browser, the first secure clinical genome browser which gives doctors unprecedented access to patients’ genetic data on their BlackBerry Passport smartphone. This platform enables deep, interactive reporting on genomics data for physicians and other treatment providers in clinical settings like giving oncologists a powerful view into the individual genetic alternations that make each patient’s disease unique and highlighting relevant treatment options.


As BlackBerry Passport features a large display screen which helps clinicians to view a patient’s chromosome at an individual base-pair level. It is the first in a series of innovative offerings being developed jointly by BlackBerry and NantHealth for use by healthcare professionals.

Security is one of the most important concern in here, NantOmics Cancer Genome Browser is fully encrypted to allow deployment in a HIPAA-secured environment, enabling clinicians to securely access patient data as soon as it’s available. BlackBerry’s recently launched BES12 cross-platform EMM solution will enable hospital IT administrators to easily deploy the application to a clinician’s BlackBerry Passport smartphone and ensures that the application data is fully secure end-to-end.

Executive Chairman and CEO, BlackBerry said :-

“BlackBerry’s partnership with NantHealth illustrates how the mobile security and collaboration technology we are known for can be reimagined to create revolutionary applications across a variety of industries, BlackBerry technology has proven itself secure, reliable and powerful enough to be counted on in life-and-death situations. Its innovative form and functionality make BlackBerry Passport an ideal addition to a doctor’s medical kit.”

Patrick Soon-Shiong, M.D., founder and CEO of NantHealth said :-

“The proprietary NantOmics Cancer Genome Browser enables clinicians for the first time to investigate a tumor genome from the full three billion bases down to the single-base level in real-time, thanks to the power of the NantOmics supercomputing infrastructure, This integrates with NantHealth’s treatment recommendation engine, Eviti, to personalize treatment protocols to individual patients based on their genomic signature.”


Some handpicked devices for you